These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34544507)

  • 21. Cognitive deficits in clinical and familial high risk groups for psychosis are common as in first episode schizophrenia.
    Üçok A; Direk N; Koyuncu A; Keskin-Ergen Y; Yüksel Ç; Güler J; Karadayı G; Akturan E; Devrim-Üçok M
    Schizophr Res; 2013 Dec; 151(1-3):265-9. PubMed ID: 24262680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of polygenic risk scores for schizophrenia and resilience on the cognition of individuals at-risk for psychosis.
    He Q; Jantac Mam-Lam-Fook C; Chaignaud J; Danset-Alexandre C; Iftimovici A; Gradels Hauguel J; Houle G; Liao C; ; Dion PA; Rouleau GA; Kebir O; Krebs MO; Chaumette B
    Transl Psychiatry; 2021 Oct; 11(1):518. PubMed ID: 34628483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subjective experience of social cognition in young people at Ultra-High Risk of psychosis: a 2-year longitudinal study.
    Pelizza L; Poletti M; Azzali S; Garlassi S; Scazza I; Paterlini F; Chiri LR; Pupo S; Raballo A
    Nord J Psychiatry; 2021 Feb; 75(2):97-108. PubMed ID: 32762506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tobacco smoking and its association with cognition in first episode psychosis patients.
    Hickling LM; Perez-Iglesias R; Ortiz-García de la Foz V; Balanzá-Martínez V; McGuire P; Crespo-Facorro B; Ayesa-Arriola R
    Schizophr Res; 2018 Feb; 192():269-273. PubMed ID: 28412088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Social cognition and neurocognition as predictors of conversion to psychosis in individuals at ultra-high risk.
    Kim HS; Shin NY; Jang JH; Kim E; Shim G; Park HY; Hong KS; Kwon JS
    Schizophr Res; 2011 Aug; 130(1-3):170-5. PubMed ID: 21620681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial.
    Mallawaarachchi SR; Amminger GP; Farhall J; Bolt LK; Nelson B; Yuen HP; McGorry PD; Markulev C; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
    Schizophr Res; 2020 Apr; 218():48-54. PubMed ID: 32171637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
    Bolt LK; Amminger GP; Farhall J; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
    Schizophr Res; 2019 Apr; 206():67-74. PubMed ID: 30558978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. General intellectual functioning as a buffer against theory-of-mind deficits in individuals at ultra-high risk for psychosis.
    Hur JW; Byun MS; Shin NY; Shin YS; Kim SN; Jang JH; Kwon JS
    Schizophr Res; 2013 Sep; 149(1-3):83-7. PubMed ID: 23810120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower prepulse inhibition in clinical high-risk groups but not in familial risk groups for psychosis compared with healthy controls.
    Togay B; Çıkrıkçılı U; Bayraktaroglu Z; Uslu A; Noyan H; Üçok A
    Early Interv Psychiatry; 2020 Apr; 14(2):196-202. PubMed ID: 31264797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurocognitive predictors of transition to psychosis: medium- to long-term findings from a sample at ultra-high risk for psychosis.
    Lin A; Yung AR; Nelson B; Brewer WJ; Riley R; Simmons M; Pantelis C; Wood SJ
    Psychol Med; 2013 Nov; 43(11):2349-60. PubMed ID: 23388122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations between saliva alpha-amylase, heart rate variability, saliva cortisol and cognitive performance in individuals at ultra high-risk for psychosis.
    Almstrup FB; Nordentoft M; Jensen MA; Kristiansen J; Kristensen TD; Wenneberg C; Garde AH; Glenthøj LB; Nordholm D
    Schizophr Res; 2023 May; 255():165-172. PubMed ID: 37001391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurocognitive performance and functional disability in the psychosis prodrome.
    Niendam TA; Bearden CE; Johnson JK; McKinley M; Loewy R; O'Brien M; Nuechterlein KH; Green MF; Cannon TD
    Schizophr Res; 2006 May; 84(1):100-11. PubMed ID: 16563699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subjective experience of social cognition in adolescents at ultra-high risk of psychosis: findings from a 24-month follow-up study.
    Pelizza L; Poletti M; Azzali S; Garlassi S; Scazza I; Paterlini F; Chiri LR; Pupo S; Raballo A
    Eur Child Adolesc Psychiatry; 2020 Dec; 29(12):1645-1657. PubMed ID: 32016572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between facial affect recognition and neurocognition in subjects at ultra-high risk for psychosis: A case-control study.
    Randers L; Jepsen JRM; Fagerlund B; Nordholm D; Krakauer K; Hjorthøj C; Glenthøj B; Nordentoft M
    Psychiatry Res; 2020 Aug; 290():112969. PubMed ID: 32450415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial.
    Glenthøj LB; Fagerlund B; Randers L; Hjorthøj CR; Wenneberg C; Krakauer K; Vosgerau A; Gluud C; Medalia A; Roberts DL; Nordentoft M
    Trials; 2015 Jan; 16():25. PubMed ID: 25623736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and to Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis.
    Hauser M; Zhang JP; Sheridan EM; Burdick KE; Mogil R; Kane JM; Auther A; Carrión RE; Cornblatt BA; Correll CU
    J Clin Psychiatry; 2017 Jan; 78(1):e28-e40. PubMed ID: 28129494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generalized neurocognitive impairment in individuals at ultra-high risk for psychosis: The possible key role of slowed processing speed.
    Randers L; Jepsen JRM; Fagerlund B; Nordholm D; Krakauer K; Hjorthøj C; Glenthøj B; Nordentoft M
    Brain Behav; 2021 Mar; 11(3):e01962. PubMed ID: 33486897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurocognitive functioning of subjects with putative pre-psychotic states and early psychosis.
    Liu CC; Hua MS; Hwang TJ; Chiu CY; Liu CM; Hsieh MH; Chien YL; Lin YT; Hwu HG
    Schizophr Res; 2015 May; 164(1-3):40-6. PubMed ID: 25802138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empathy and Its Relationship With Social Functioning in Individuals at Ultra-High Risk for Psychosis.
    Kuis DJ; van de Giessen T; de Jong S; Sportel BE; Boonstra N; van Donkersgoed R; Lysaker PH; Hasson-Ohayon I; Pijnenborg GHM
    Front Psychiatry; 2021; 12():730092. PubMed ID: 34858222
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.